Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05SCQ
|
||||
Former ID |
DIB016969
|
||||
Drug Name |
TDI-0079
|
||||
Synonyms |
Superoxide dismutase-1 (SOD1) gene modulator (amyotrophic lateral sclerosis), ALS Therapy Development Foundation
|
||||
Indication | Motor neurone disease [ICD9: 335.2; ICD10:G12.2] | Investigative | [528378] | ||
Company |
ALS Therapy Development Foundation Inc
|
||||
Target and Pathway | |||||
Target(s) | Superoxide dismutase [Cu-Zn] | Target Info | Modulator | [528378] | |
BioCyc Pathway | Reactive oxygen species degradation | ||||
NetPath Pathway | TCR Signaling Pathway | ||||
Pathway Interaction Database | Validated nuclear estrogen receptor alpha network | ||||
FOXA1 transcription factor network | |||||
PathWhiz Pathway | Degradation of Superoxides | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.